Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS)

NCT04296903 is registered in ClinicalTrials.gov with Apifix as lead sponsor.

NCT NCT04296903
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04296903 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS)
Lead sponsor
Apifix
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 31, 2020
Completion date
June 30, 2030
Enrollment
201 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

adolescent idiopathic scoliosis